Back to Search Start Over

Comorbidities in Patients with Lichen Planopilaris: A Case-Control Study.

Authors :
Nasimi M
Garmaroudi G
Ghiasi M
Lajevardi V
Fooladi Z
Hassan Zadeh Tabatabaei MS
Ansari MS
Source :
Skin appendage disorders [Skin Appendage Disord] 2022 Jul; Vol. 8 (4), pp. 302-306. Date of Electronic Publication: 2022 Mar 09.
Publication Year :
2022

Abstract

Introduction: Lichen planopilaris (LPP) is a lymphocyte-mediated type of scarring alopecia and considered to have autoimmune etiology. Studies about systemic comorbid conditions are limited. Our goal is to identify the prevalence of medical comorbidities in patients with LPP.<br />Methods: In a retrospective case-control study, the medical records of 208 LPP patients and 208 controls were reviewed for existing comorbidities such as thyroid diseases, cardiovascular disorders, hypertension, hyperlipidemia, and lupus erythematous.<br />Results: Hyperlipidemia was found in 41.8% of all patients with LPP and in 17.3% of controls ( p value <0.001, OR = 4.167). Chances of hypertension and cardiovascular disorders were lower in the LPP group in comparison to controls ( p value = 0.009). Thyroid disorders were more prevalent in LPP patients, but the difference was not statistically significant ( p value = 0.277).<br />Conclusion: Our study further emphasizes that LPP patients should be screened for medical comorbidities, especially lipid profile abnormalities.<br />Competing Interests: The authors have no conflicts of interest to declare.<br /> (Copyright © 2022 by S. Karger AG, Basel.)

Details

Language :
English
ISSN :
2296-9195
Volume :
8
Issue :
4
Database :
MEDLINE
Journal :
Skin appendage disorders
Publication Type :
Academic Journal
Accession number :
35983472
Full Text :
https://doi.org/10.1159/000522371